vs
科迪华（CTVA）与维谛技术（VRT）财务数据对比。点击上方公司名可切换其他公司
科迪华的季度营收约是维谛技术的1.5倍（$3.9B vs $2.6B），维谛技术净利率更高（14.7% vs -14.1%，领先28.8%），维谛技术同比增速更快（30.1% vs -1.7%），科迪华自由现金流更多（$4.2B vs $652.8M），过去两年维谛技术的营收复合增速更高（16.5% vs -6.7%）
科迪华是一家美国农业科技企业，主营种子与作物保护产品，涵盖除草剂、杀虫剂、杀菌剂及生物制剂，业务覆盖全球110个国家，总部位于印第安纳州印第安纳波利斯，旗下大部分种子产品以先锋良种国际品牌销售。
维谛技术（Vertiv）是一家美国跨国企业，专注于为数据中心、通信网络、商业及工业场景提供关键基础设施及配套服务，旗下方案可有效保障各行业客户关键业务系统的稳定高效运行。
CTVA vs VRT — 直观对比
营收规模更大
CTVA
是对方的1.5倍
$2.6B
营收增速更快
VRT
高出31.8%
-1.7%
净利率更高
VRT
高出28.8%
-14.1%
自由现金流更多
CTVA
多$3.5B
$652.8M
两年增速更快
VRT
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.9B | $2.6B |
| 净利润 | $-552.0M | $390.1M |
| 毛利率 | 42.4% | 37.7% |
| 营业利润率 | -13.6% | — |
| 净利率 | -14.1% | 14.7% |
| 营收同比 | -1.7% | 30.1% |
| 净利润同比 | -1246.3% | 137.1% |
| 每股收益（稀释后） | $-0.80 | $0.99 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTVAVRT
| Q1 26 | — | $2.6B | ||
| Q4 25 | $3.9B | $2.9B | ||
| Q3 25 | $2.6B | $2.7B | ||
| Q2 25 | $6.5B | $2.6B | ||
| Q1 25 | $4.4B | $2.0B | ||
| Q4 24 | $4.0B | $2.3B | ||
| Q3 24 | $2.3B | $2.1B | ||
| Q2 24 | $6.1B | $2.0B |
净利润CTVAVRT
| Q1 26 | — | $390.1M | ||
| Q4 25 | $-552.0M | $445.6M | ||
| Q3 25 | $-320.0M | $398.5M | ||
| Q2 25 | $1.3B | $324.2M | ||
| Q1 25 | $652.0M | $164.5M | ||
| Q4 24 | $-41.0M | $147.0M | ||
| Q3 24 | $-524.0M | $176.6M | ||
| Q2 24 | $1.1B | $178.1M |
毛利率CTVAVRT
| Q1 26 | — | 37.7% | ||
| Q4 25 | 42.4% | 38.9% | ||
| Q3 25 | 37.2% | 37.8% | ||
| Q2 25 | 54.6% | 34.0% | ||
| Q1 25 | 47.0% | 33.7% | ||
| Q4 24 | 37.3% | 37.1% | ||
| Q3 24 | 32.7% | 36.5% | ||
| Q2 24 | 52.3% | 38.0% |
营业利润率CTVAVRT
| Q1 26 | — | — | ||
| Q4 25 | -13.6% | 20.1% | ||
| Q3 25 | -14.1% | 19.3% | ||
| Q2 25 | 27.9% | 16.8% | ||
| Q1 25 | 17.7% | 14.3% | ||
| Q4 24 | 2.2% | 19.5% | ||
| Q3 24 | -27.2% | 17.9% | ||
| Q2 24 | 21.9% | 17.2% |
净利率CTVAVRT
| Q1 26 | — | 14.7% | ||
| Q4 25 | -14.1% | 15.5% | ||
| Q3 25 | -12.2% | 14.9% | ||
| Q2 25 | 20.4% | 12.3% | ||
| Q1 25 | 14.8% | 8.1% | ||
| Q4 24 | -1.0% | 6.3% | ||
| Q3 24 | -22.5% | 8.5% | ||
| Q2 24 | 17.2% | 9.1% |
每股收益（稀释后）CTVAVRT
| Q1 26 | — | $0.99 | ||
| Q4 25 | $-0.80 | $1.14 | ||
| Q3 25 | $-0.47 | $1.02 | ||
| Q2 25 | $1.92 | $0.83 | ||
| Q1 25 | $0.95 | $0.42 | ||
| Q4 24 | $-0.05 | $0.38 | ||
| Q3 24 | $-0.76 | $0.46 | ||
| Q2 24 | $1.51 | $0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $2.5B |
| 总债务越低越好 | $1.7B | $0 |
| 股东权益账面价值 | $24.1B | $4.2B |
| 总资产 | $42.8B | $13.4B |
| 负债/权益比越低杠杆越低 | 0.07× | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资CTVAVRT
| Q1 26 | — | $2.5B | ||
| Q4 25 | $4.5B | $1.7B | ||
| Q3 25 | $2.6B | $1.4B | ||
| Q2 25 | $2.1B | $1.6B | ||
| Q1 25 | $2.0B | $1.5B | ||
| Q4 24 | $3.2B | $1.2B | ||
| Q3 24 | $2.5B | $908.7M | ||
| Q2 24 | $2.0B | $579.7M |
总债务CTVAVRT
| Q1 26 | — | $0 | ||
| Q4 25 | $1.7B | $2.9B | ||
| Q3 25 | $1.7B | $2.9B | ||
| Q2 25 | $1.7B | $2.9B | ||
| Q1 25 | $1.8B | $2.9B | ||
| Q4 24 | $2.0B | $2.9B | ||
| Q3 24 | $2.0B | $2.9B | ||
| Q2 24 | $2.5B | $2.9B |
股东权益CTVAVRT
| Q1 26 | — | $4.2B | ||
| Q4 25 | $24.1B | $3.9B | ||
| Q3 25 | $25.2B | $3.5B | ||
| Q2 25 | $25.9B | $3.1B | ||
| Q1 25 | $24.3B | $2.7B | ||
| Q4 24 | $23.8B | $2.4B | ||
| Q3 24 | $24.7B | $1.8B | ||
| Q2 24 | $25.2B | $1.5B |
总资产CTVAVRT
| Q1 26 | — | $13.4B | ||
| Q4 25 | $42.8B | $12.2B | ||
| Q3 25 | $42.2B | $10.8B | ||
| Q2 25 | $41.8B | $10.4B | ||
| Q1 25 | $42.1B | $9.5B | ||
| Q4 24 | $40.8B | $9.1B | ||
| Q3 24 | $41.9B | $8.9B | ||
| Q2 24 | $41.5B | $8.1B |
负债/权益比CTVAVRT
| Q1 26 | — | 0.00× | ||
| Q4 25 | 0.07× | 0.74× | ||
| Q3 25 | 0.07× | 0.83× | ||
| Q2 25 | 0.07× | 0.93× | ||
| Q1 25 | 0.07× | 1.10× | ||
| Q4 24 | 0.08× | 1.20× | ||
| Q3 24 | 0.08× | 1.62× | ||
| Q2 24 | 0.10× | 1.91× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.4B | — |
| 自由现金流经营现金流 - 资本支出 | $4.2B | $652.8M |
| 自由现金流率自由现金流/营收 | 106.2% | 24.6% |
| 资本支出强度资本支出/营收 | 5.7% | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $2.8B | $2.3B |
8季度趋势，按日历期对齐
经营现金流CTVAVRT
| Q1 26 | — | — | ||
| Q4 25 | $4.4B | $978.9M | ||
| Q3 25 | $193.0M | $508.7M | ||
| Q2 25 | $947.0M | $322.9M | ||
| Q1 25 | $-2.1B | $303.3M | ||
| Q4 24 | $4.2B | $425.2M | ||
| Q3 24 | $130.0M | $378.2M | ||
| Q2 24 | $451.0M | $378.4M |
自由现金流CTVAVRT
| Q1 26 | — | $652.8M | ||
| Q4 25 | $4.2B | $885.6M | ||
| Q3 25 | $36.0M | $463.5M | ||
| Q2 25 | $829.0M | $277.9M | ||
| Q1 25 | $-2.2B | $266.8M | ||
| Q4 24 | $4.0B | $364.5M | ||
| Q3 24 | $-24.0M | $341.8M | ||
| Q2 24 | $337.0M | $344.3M |
自由现金流率CTVAVRT
| Q1 26 | — | 24.6% | ||
| Q4 25 | 106.2% | 30.8% | ||
| Q3 25 | 1.4% | 17.3% | ||
| Q2 25 | 12.8% | 10.5% | ||
| Q1 25 | -49.9% | 13.1% | ||
| Q4 24 | 100.4% | 15.5% | ||
| Q3 24 | -1.0% | 16.5% | ||
| Q2 24 | 5.5% | 17.6% |
资本支出强度CTVAVRT
| Q1 26 | — | 4.2% | ||
| Q4 25 | 5.7% | 3.2% | ||
| Q3 25 | 6.0% | 1.7% | ||
| Q2 25 | 1.8% | 1.7% | ||
| Q1 25 | 2.1% | 1.8% | ||
| Q4 24 | 4.6% | 2.6% | ||
| Q3 24 | 6.6% | 1.8% | ||
| Q2 24 | 1.9% | 1.7% |
现金转化率CTVAVRT
| Q1 26 | — | — | ||
| Q4 25 | — | 2.20× | ||
| Q3 25 | — | 1.28× | ||
| Q2 25 | 0.72× | 1.00× | ||
| Q1 25 | -3.23× | 1.84× | ||
| Q4 24 | — | 2.89× | ||
| Q3 24 | — | 2.14× | ||
| Q2 24 | 0.43× | 2.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTVA
| Corn | $1.4B | 35% |
| Herbicides | $1.1B | 27% |
| Insecticides | $488.0M | 12% |
| Fungicides | $272.0M | 7% |
| Biologicals | $191.0M | 5% |
| Soybean | $164.0M | 4% |
| Other | $160.0M | 4% |
| Otheroilseeds | $94.0M | 2% |
VRT
暂无分部数据
